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Summary
Mutations in the NALP3/CIAS1/cryopyrin gene are
linked to three autoinflammatory disorders: Muckle-
Wells syndrome, familial cold autoinflammatory syn-
drome, and chronic infantile neurologic cutaneous
and articular syndrome. NALP3, with the adaptor mol-
ecule ASC, has been proposed to form a caspase-1-
activating ‘‘inflammasome,’’ a complex with pro-IL1b-
processing activity. Here, we demonstrate the effect
of NALP3 deficiency on caspase-1 function. NALP3
was essential for the ATP-driven activation of
caspase-1 in lipopolysaccharide-stimulated macro-
phages and for the efficient secretion of the caspase-
1-dependent cytokines IL-1a, IL-1b, and IL-18. IL-1b
has been shown to play a key role in contact hypersen-
sitivity; we show that ASC- and NALP3-deficient mice
also demonstrate an impaired contact hypersensitivity
response to the hapten trinitrophenylchloride. NALP3,
however, was not required for caspase-1 activation by
Salmonella typhimurium, and NALP3 deficiency only
partially protects mice from the lethal effects of endo-
toxin. These data suggest that NALP3 plays a specific
role in the caspase-1 activation pathway.
Introduction
Interleukin (IL)-1b and IL-18 are both proinflammatory
cytokines involved in host response to infection and in-
jury. Excessive production of these cytokines is associ-
ated with septic shock and autoimmune disorders. Both
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10 Present address: Medimmune, Gaithersburg, Maryland 20878.IL-1b and IL-18 are produced as inactive cytoplasmic
precursors (pro-IL-1b and pro-IL-18), which are cleaved
by caspase-1 (IL-1b-converting enzyme [ICE]) to their
mature active forms (Dinarello, 1998). Recently, IL-33
has also been described to be cleaved by caspase-1
(Schmitz et al., 2005). Recent studies have suggested
that caspase-1 is activated in a complex termed the ‘‘in-
flammasome’’ (Agostini et al., 2004; Martinon et al.,
2002). Overexpression studies have reported that ASC
(apoptosis-associated speck-like protein containing
a CARD [caspase-recruitment domain]; also known as
Pycard or TMS1) and NALP3 can activate caspase-1
(Agostini et al., 2004). ASC contains a C-terminal CARD
as well as an N-terminal Pyrin domain (PYD, PAAD,
DAPIN) (Conway et al., 2000; Martinon et al., 2002;
Masumoto et al., 1999). The CARD domain within ASC
binds to the caspase-1 CARD domain (Srinivasula
et al., 2002; Stehlik et al., 2003; Wang et al., 2002), and re-
cent studies utilizing ASC-deficient mice have shown
that ASC plays a key role in caspase-1 activation (Maria-
thasan et al., 2004; Yamamoto et al., 2004). The PYD of
ASC interacts with the PYD of NALP3. NALP3, also
known as cryopyrin/CIAS1/PYPAF1, is a member of
the NACHT-LRR (NLR) family (Inohara et al., 2005;
Martinon and Tschopp, 2005, Ting and Davis, 2005).
Mutations within the NALP3 gene are responsible for
three autoinflammatory disorders, Muckle-Wells syn-
drome (MWS), familial cold autoinflammatory syndrome
(FCAS), and chronic infantile neurological cutaneous
and articular syndrome (CINCA), which compose a sub-
set of the periodic fever syndromes (Hoffman et al.,
2001). The mutations within NALP3 seen in MWS,
FCAS, and CINCA are thought to result in a constitutively
active form of NALP3 that causes the spontaneous acti-
vation of caspase-1 and the hypersecretion of IL-1b.
However, the physiological importance of NALP3 in cas-
pase-1 activation and IL-1b production remains unclear.
We report here a mouse strain deficient in NALP3, and
we demonstrate that NALP3 is required for the ATP-
driven activation of caspase-1 in response to multiple
TLR ligands. We also demonstrate that NALP3 is in-
volved in a specific caspase-1 activation pathway for
the processing of proinflammatory cytokines, but not
Salmonella-induced cell death. Taken together, these
data help to delineate a critical role for NALP3 in cas-
pase-1 activation.
Results
Expression of NALP3
The tissue distribution of mouse NALP3 mRNA was ex-
amined by using RT-PCR analysis (Figure 1A). NALP3
mRNA was detected in all tissues examined, with the ex-
ception of thymus. This is in contrast to Northern blot
analysis of human tissues where NALP3 expression
was found to be restricted to peripheral blood leuko-
cytes (Manji et al., 2002). Anderson et al. (2004) recently
examined the expression of NALP3 in mouse tissues by
quantitative real-time PCR, and they also noted NALP3
expression in a wide variety of tissues, with particularly
Immunity
318Figure 1. Expression of Mouse NALP3 mRNA
(A) NALP3 expression in C57BL/6 tissue was determined by RT-PCR.
(B) NALP3 expression in bone marrow-derived macrophages (BMM), BMM stimulated with 50 ng/ml LPS for 6 hr, T helper cell 0 (Th0), Th1, Th2,
GR1+ neutrophils isolated from bone marrow by using positive selection beads (Miltenyi Biotec), CD19+ B cells isolated from spleens by using
positive selection beads, and bone marrow-derived dendritic cells (BMDC) was determined by RT-PCR.
(C) BMM and BMDC were stimulated with 50 ng/ml LPS for 3 hr or the indicated times, and RNA was isolated and used to generate cDNA.
Neutrophils, B cells, and T cells were isolated as described in (B). NALP3 expression was determined by quantitative RT-PCR analysis.high expression in the skin and eye. We also detected
NALP3 mRNA by RT-PCR and SYBR green quantitative
RT-PCR analysis in various primary immune cells (Fig-
ures 1B and 1C). NALP3 is expressed in a variety of rest-
ing immune cells, including macrophages, dendritic
cells, and neutrophils, and it is seen at low levels in B
cells (Figures 1B and 1C). The expression of NALP3
mRNA was upregulated in Th2 cells compared to Th1
and Th0 cells (Figures 1B and 1C). There does not, how-
ever, appear to be a defect in the ability of NALP3-defi-
cient CD4+ cells to be differentiated into Th1 or Th2 cells
in vitro (data not shown). The expression of NALP3 in
macrophages was increased by lipopolysaccharide
(LPS) stimulation (Figures 1B and 1C). Real-time PCR
analysis carried out on cDNA isolated from LPS-stimu-
lated macrophages demonstrated that the NALP3
message was maximally upregulated 1 hr after LPS
stimulation (Figure 1C), which correlates well with the
expression of human NALP3, which is also inducible
by TLR agonists (O’Connor et al., 2003).
NALP3 Is Required for Caspase-1 Activation
in TLR-Stimulated Macrophages
We investigated the role of NALP3 in the caspase-1-
dependent secretion of IL-1b in vitro by using NALP3-
deficient bone marrow-derived macrophages. The syn-
thesis, processing, and release of IL-1b by macrophages
require two stimuli. An inflammatory stimulus, such as
LPS, induces large intracellular stores of the 31 kDa
pro-IL-1b, and a second stimulus results in the releaseof the active mature 17 kDa IL-1b. The second stimulus
can be a variety of agents, such as ATP, nigericin, and
bacterial toxins (Cheneval et al.,1998; Monack et al.,
2001; Perregaux and Gabel, 1994). These stimuli also
probably cause the autocatalytic processing of the 45
kDa caspase-1 to generate the two subunits p20 and
p10. Macrophages from NALP3+/+ and NALP32/2 mice
were assessed for caspase-1 activation and IL-1b re-
lease after treatment with LPS and ATP. ATP induces
the caspase-1-dependent maturation of IL-1b by acti-
vating P2X7 receptors, which results in the rapid efflux
of intracellular K+ (Solle et al., 2001). Unlike NALP3+/+
macrophages, NALP32/2macrophages did not process
caspase-1 in response to LPS and ATP, as measured by
the detection of the p10 subunit of caspase-1 (Fig-
ure 2A). We examined if the defect in caspase-1 activa-
tion had any effect on the production and secretion of IL-
1b. Western blot analysis revealed comparable amounts
of pro-IL-1b induced in LPS-treated NALP3+/+ and
NALP32/2 macrophages (Figure 2B). There was, how-
ever, a decrease in intracellular pro-IL-1b detected in
NALP3+/+ macrophages treated with LPS plus ATP in
comparison to macrophages treated with LPS alone;
this decrease likely reflects the processing and secre-
tion of IL-1b. This decrease in pro-IL-1b after LPS plus
ATP treatment was not detected in NALP32/2 macro-
phages. Secreted IL-1b levels in the supernatants of
stimulated macrophages was determined by ELISA
(Figure 2C). NALP3+/+ macrophages expectedly se-
creted IL-1b in response to LPS plus ATP, but not to
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319Figure 2. NALP3 Is Required for Caspase-1 Activation and Secretion of IL-1b
(A and B) Bone marrow-derived macrophages were stimulated with or without LPS (10 ng/ml) for 6 hr and then treated with 1 mM ATP for 30 min.
Cell lysates were immunoblotted with antibodies against the p10 subunit of (A) caspase-1 and (B) IL-1b. Results in (A) are representative of two
separate experiments.
(C and D) (C) IL-1b release into culture supernatants was measured by ELISA. (D) Bone marrow-derived macrophages were stimulated with LPS
(10 ng/ml) for 6 hr, followed by stimulation with 1 mM ATP for the indicated times, and IL-1b released into culture supernatants was measured by
ELISA. (C and D) Determinations were performed in triplicate and were expressed as the mean 6 SD. Results in (C) are representative of four
separate experiments.either stimulus alone, consistent with the decrease seen
in intracellular pro-IL-1b. Release of IL-1b after LPS
priming and ATP treatment was markedly impaired in
NALP32/2 macrophages (Figure 2C), indicating a spe-
cific requirement for NALP3 in the caspase-1-depen-
dent secretion of IL-1b. LPS-stimulated NALP3-defi-
cient macrophages treated with ATP for up to 60 min
still did not secrete IL-1b (Figure 2D), suggesting that
NALP3 is required for caspase-1-mediated secretion
of IL-1b in response to LPS plus ATP and does not
merely delay this process. Recent studies have demon-
strated similar defects in caspase-1 activation and IL-1b
secretion in macrophages from ASC-deficient mice (Ma-riathasan et al., 2004). Our results demonstrate that like
ASC, NALP3 is indispensable for caspase-1 activation in
response to LPS plus ATP.
The roles of ASC and NALP3 in caspase-1 activation
and IL-1b secretion led us to evaluate if other caspase-
1-dependent cytokines were affected by ASC and
NALP3 deficiency. IL-18 is a proinflammatory cytokine
produced as a 24 kDa precursor and processed to an
18 kDa mature form by caspase-1. Although pro-IL-1a
is not a substrate for caspase-1, caspase-1 deficiency
has been shown to also affect the secretion of IL-1a
(Kuida et al., 1995; Li et al., 1995). Release of IL-1a and
IL-1b from TLR-primed and ATP-treated ASC2/2
Immunity
320Figure 3. NALP3 Is Required for Secretion of IL-1a, IL-1b, and IL-18 in Response to TLR Agonists Plus ATP
(A and B) Thioglycollate-elicited peritoneal macrophages were stimulated with LPS (50 ng/ml), PGN (5 mg/ml), LTA (10 mg/ml), or at the concen-
tration indicated, for 16 hr, pulsed with 5 mM ATP for 20 min, and then further incubated in fresh medium for 3 hr. (A) IL-1b (upper panel), (A) IL-1a
(middle panel), and (B) IL-18 release into culture supernatants was measured by ELISA. (A) TNFa (lower panel), (B) IL-12 p40, and (B) IL-6 secreted
during the initial 16 hr incubation were measured by ELISA. In (A), results are representative of two separate experiments.
(C) Bone marrow-derived macrophages were stimulated with or without LPS (10 ng/ml) or lipid A (1 mg/ml) for 6 hr, followed by stimulation with
1 mM ATP for 30 min. IL-1b release into culture supernatants was measured by ELISA.
(D) Bone marrow-derived macrophages were stimulated with LPS (1 ng/ml) or MDP (10 mg/ml) or both LPS plus MDP for 6 hr, followed by incu-
bation with or without 1 mM ATP for 30 min. IL-1b and TNFa release into culture supernatants was measured by ELISA (panels 1 and 3). Intra-
cellular pro-IL-1b and IL-1b were detected by lysing macrophage monolayers with 1% Nonidet P40 and measuring IL-1b in cell lysates by ELISA
(panel 2).
In (A)–(D), determinations were performed in triplicate and are expressed as the mean 6 SD.macrophages was reduced when compared to ASC+/+
macrophages (see Figure S1 in the Supplemental Data
available with this article online), confirming the findings
of others that used independently derived ASC-deficientmouse strains (Mariathasan et al., 2004). The release of
IL-1a and IL-1b from TLR-primed and ATP-treated
NALP32/2 macrophages was also markedly reduced
compared to NALP3+/+ macrophages (Figure 3A). This
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agent, but also in response to peptidoglycan (PGN), lip-
oteichoic acid (LTA), and synthetic lipid A (Figures 3A
and 3C). NALP3+/+ and NALP32/2 macrophages se-
creted comparable amounts of the proinflammatory cy-
tokine TNFa (Figure 3A). The release of IL-18 from TLR-
primed and ATP-treated NALP32/2 macrophages was
also decreased compared to NALP3+/+ macrophages
(Figure 3B). In contrast, no significant difference in IL-6
and IL-12 p40 production was seen in NALP32/2macro-
phages compared to NALP3+/+ macrophages (Fig-
ure 3B), further suggesting that NALP3 is specifically
required for caspase-1-dependent secretion of IL-1a,
IL-1b, and IL-18. Bacterial muramyl dipeptide (MDP)
has been recently proposed to activate NALP3 (Marti-
non et al., 2004). MDP is also the ligand for NOD2, which
is also an NLR family member (Girardin et al., 2003; Ino-
hara et al., 2003). Macrophages stimulated with MDP
alone did not secrete detectable amounts of IL-1b or
TNFa (Figure 3D). MDP enhanced LPS-induced secre-
tion of TNFa in both NALP3+/+ and NALP32/2 macro-
phages (Figure 3D). Intracellular pro-IL-1b was en-
hanced by MDP plus LPS in both NALP3+/+ and
NALP32/2 macrophages (Figure 3D). MDP also en-
hanced caspase-1-dependent IL-1b secretion from
NALP3+/+ macrophages, but no secretion of IL-1b was
detected in NALP32/2 macrophages (Figure 3D). Be-
cause NALP3 was required for IL-1b secretion in re-
sponse to LPS plus ATP, we could not evaluate if the
enhancement in IL-1b secretion seen in LPS plus
MDP-treated wild-type macrophages was due to the
interaction of NALP3 with MDP. Our data do demon-
strate a crucial role for NALP3 in the ATP-driven activa-
tion of caspase-1.
Role of NALP3 in Endotoxic Shock
Wild-type mice treated with high doses of endotoxin
produce multiple proinflammatory cytokines, which are
thought to mediate the lethal effects of endotoxin. Cas-
pase-1-deficient mice have been shown to have in-
creased resistance to the lethal effect of a high dose of
LPS, demonstrating a central role for caspase-1 in medi-
ating inflammatory responses in vivo (Kuida et al., 1995;
Li et al., 1995). To determine if ASC and NALP3 are in-
volved in the lethal effects seen with caspase-1 activa-
tion in response to LPS, the sensitivity of ASC- and
NALP3-deficient mice to endotoxic shock was deter-
mined. ASC+/+ and ASC2/2 mice were injected intraper-
itoneally with a lethal dose of 37.5 mg/kg LPS. By 24 hr,
90% of ASC+/+ mice had died; however, only 15% of
ASC2/2 mice had died by 24 hr, with a maximum of
30% mortality at day 7 (Figure 4A). ASC2/2 mice chal-
lenged with LPS also demonstrated significantly de-
creased serum IL-1b and IL-18 levels compared to
ASC+/+ mice (Figure 4E). These data are consistent
with those of others who also noted increased resis-
tance and decreased serum IL-1b and IL-18 levels in
ASC2/2 mice in response to LPS compared to wild-
type mice (Mariathasan et al., 2004). In contrast to the in-
creased resistance to endotoxic shock seen in ASC2/2
mice, death occurred with a similar time course in
NALP3+/+ and NALP32/2 mice when challenged with
a lethal dose of 37.5 mg/kg LPS (Figure 4B). No en-
hanced survival to endotoxic shock was observed inNALP32/2 mice despite significantly reduced amounts
of serum IL-1b and IL-18 in response LPS (Figure 4E).
Serum concentrations of TNFa in response to LPS
were similar in both NALP3+/+ and NALP32/2 mice
(Figure 4E). These data suggest that the protective ef-
fect of ASC and caspase-1 deficiency seen in endotoxic
shock is not due to defects in IL-1b and IL-18 produc-
tion. These findings also demonstrate a divergence in
the roles of NALP3 with those of ASC and caspase-1.
However, when NALP32/2 mice were challenged with
lower doses of LPS (18.75 and 9.38 mg/kg), some de-
gree of protection was observed (Figures 4C and 4D).
NALP32/2 mice challenged with 18.75 mg/kg LPS
showed a delay in mortality compared to NALP3+/+
mice (Figure 4C). In mice challenged with 9.38 mg/kg
LPS (Figure 4D), 87.5% of NALP32/2 mice survived,
compared to only 25% of NALP3+/+ mice by day 7. These
data suggest that NALP3 plays a partial role in protec-
tion from endotoxic shock, although to a far lesser de-
gree than observed with ASC.
Salmonella typhimurium Can Activate Caspase-1
Independently of NALP3
Caspase-1 has been shown to play an important role in
host resistance to Salmonella infections, and macro-
phages infected with S. typhimurium undergo a cas-
pase-1-dependent cell death (Hueffer and Gala´n,
2004). The Salmonella pathogenicity island (SPI)-1-en-
coded protein SipB has been postulated to bind to
and activate caspase-1, thereby causing macrophage
cell death (Hersh et al., 1999). To test whether ASC
and NALP3 are also involved in S. typhimurium-induced
cell death, wild-type ASC2/2 and NALP32/2 macro-
phages were infected with S. typhimurium, and cell
death was measured by lactate dehydrogenase (LDH)
release. ASC has previously been implicated in S. typhi-
murium-induced cell death (Mariathasan et al., 2004),
and we were able to confirm that ASC2/2 macrophages
display a delayed cell death in response to S. typhimu-
rium infection (data not shown); however, by 60 min,
ASC+/+ and ASC2/2 macrophages displayed similar
cell death in response to S. typhimurium. The delay in
S. typhimurium-induced cell death seen in ASC2/2mac-
rophages was not observed in NALP32/2 macrophages
(Figure 5A). Both NALP3+/+ and NALP32/2macrophages
displayed a similar level of cell death in response to in-
fection with S. typhimurium at all of the time points ex-
amined. As expected, the invG mutant strain of S. typhi-
murium, defective in the type III secretion system, did
not kill NALP3+/+ or NALP32/2macrophages (Figure 5A).
We next examined the effect of S. typhimurium on cas-
pase-1 activation. LPS plus ATP treatment resulted in
the activation of caspase-1 in wild-type macrophages,
but not in NALP3-deficient macrophages (Figure 5B).
Wild-type macrophages challenged withS. typhimurium
also rapidly activated caspase-1 (Figure 5B). ASC-defi-
cient macrophages challenged with S. typhimurium
failed to produce detectable amounts of the p10 subunit
of caspase-1 (data not shown; Mariathasan et al., 2004),
consistent with the findings of a delayed Salmonella-in-
duced cell death in ASC2/2 macrophages. However,
NALP32/2 macrophages infected with S. typhimurium
were capable of activating caspase-1, as measured
by the detection of the p10 subunit of caspase-1
Immunity
322Figure 4. Susceptibility of ASC- and NALP3-Deficient Mice to Endotoxic Shock
(A–D) Mice were injected intraperitoneally with the indicated dose of LPS (37.5, 18.75, or 9.38 mg/kg), and survival was followed for 7 days. In (B),
data are representative of two independent experiments.
(E) Wild-type, ASC2/2, and NALP32/2 mice were injected intraperitonaelly with LPS (37.5 mg/kg); 5 hr after LPS injection, mice were euthanized
and blood was collected by cardiac puncture. Serum IL-1b, IL-18, and TNFa concentrations were measured by ELISA. Serum from untreated
wild-type mice was used as a control. Data represent the mean 6 SD for 3–4 mice of each genotype.(Figure 5B). NALP32/2 macrophages infected with S. ty-
phimurium were also capable of producing IL-1b, as de-
tected by ELISA (Figure 5C). These findings again are
consistent with a distinct role for NALP3 and ASC in cas-
pase-1 function, since NALP32/2 macrophages did not
show the delay inS. typhimurium-induced cell death ob-
served in ASC2/2 macrophages. Furthermore, although
ASC appears to be is involved in S. typhimurium-medi-
ated caspase-1 activation, S. typhimurium can activate
caspase-1 independently of NALP3.
ASC- and NALP3-Deficient Mice Display Impaired
Contact Hypersensitivity
Contact hypersensitivity is a T cell-mediated cellular im-
mune response to repeated epicutaneous exposure to
contact allergens. Contact hypersensitivity can be di-
vided into two phases: sensitization and elicitation. IL-
1b has been implicated to play a central role in contact
hypersensitivity to trinitrophenylchloride (TNP-Cl), pri-
marily at the sensitization phase. Mice treated with neu-tralizing antibodies to IL-1b or mice deficient in IL-1b
have impaired contact hypersensitivity to TNP-Cl (Enk
et al., 1993; Shornick et al., 1996). In order to determine
if ASC and NALP3 are involved in contact hypersensitiv-
ity, we examined the responsiveness of wild-type,
ASC2/2, and NALP32/2 mice after sensitization with
TNP-Cl. Wild-type, ASC2/2, and NALP32/2 mice were
sensitized with 150 ml 5% TNP-Cl on 2 consecutive
days, and they were then challenged by painting 10 ml
0.4% TNP-Cl onto both ears 4 days later. Significant
ear swelling was detected in the ears of ASC+/+ and
NALP3+/+ mice at the site of challenge at 24 hr (Figures
6A and 6B). In contrast, ASC2/2 and NALP32/2 mice
showed no increase in 24 hr ear swelling compared to
nonsensitized control mice. To determine at which stage
of the TNP-Cl response NALP3 is involved, we trans-
ferred splenocytes and lymph node cells from wild-
type TNP-Cl-sensitized mice into naı¨ve NALP3+/+ versus
NALP32/2 recipients (Figure 6C). The recipient mice
were challenged with 0.4% TNP-Cl, and ear swelling
Critical Role for NALP3 in Caspase-1 Activation
323Figure 5. Unaltered S. typhimurium-Induced Cell Death in NALP3-Deficient Macrophages
(A) LPS-stimulated bone marrow-derived macrophages from NALP3+/+ and NALP32/2mice were infected with either wild-typeS. typhimurium or
invG mutant S. typhimurium at an MOI of 20 bacteria per macrophage, and cytotoxicity was measured by LDH release. Cytotoxicity is expressed
as a percentage of LDH release by Triton X-100 detergent. Determinations were performed in triplicate and are expressed as the mean 6 SD.
Results are representative of three separate experiments.
(B and C) LPS-stimulated bone marrow-derived macrophages from NALP3+/+ and NALP32/2 mice were either stimulated with 1 mM ATP for 30
min or infected with wild-type S. typhimurium at an MOI of 10 bacteria per macrophage for 2 hr. Caspase-1 cleavage in cell lysates was then
detected by Western blotting with an (B) anti-caspase-1 p10 antibody, and (C) IL-1b release into the culture supernatants was measured by
ELISA.was measured at 24 hr. As expected, unsensitized
NALP3+/+ mice that received cells from sensitized wild-
type mice developed ear swelling comparable to ac-
tively TNP-Cl-sensitized NALP3+/+ mice upon TNP-Cl
challenge. Unsensitized NALP32/2 mice that received
cells from sensitized wild-type mice also developed
ear swelling comparable to that seen in NALP3+/+
mice (Figure 6C). This suggests that the defect seen in
TNP-Cl contact hypersensitivity in NALP3-deficient
mice is occurring at the sensitization step, as an appro-
priate elicitation response occurs in NALP32/2 mice
that have received effector cells from sensitized wild-
type mice. Together, these data demonstrate a signifi-
cant defect in the ability of ASC- and NALP3-deficient
mice to manifest a contact hypersensitivity response
to TNP-Cl.
Discussion
Our results demonstrate that both NALP3 and ASC are
required for caspase-1 activation in macrophages in re-
sponse to TLR stimulation plus ATP. This defect in cas-
pase-1 activation seen in NALP3-deficient macro-
phages affects the subsequent production of the
caspase-1-dependent cytokines IL-1a, IL-1b, and IL-18
(Figures 3A–3C). Although NALP3 has been reported to
attenuate NF-kB activity (O’Connor et al., 2003), we did
not observe any consistent differences in the production
of TNFa, IL-6, or IL-12 p40 from NALP32/2macrophages
(Figures 3A and 3C), suggesting that NALP3 does not in-
fluence macrophage NF-kB activity, but specifically af-
fects caspase-1. NALP3 along with ASC have been pro-
posed to form a caspase-1-activating inflammasome
(Agostini et al., 2004). The existence of the inflamma-
some under physiologic conditions in primary cells re-
mains to be shown. We postulate, however, that in this
model NALP3 would be activated by an upstream signal
induced by ATP plus TLR stimulation, and would then go
on to activate ASC and caspase-1. Although it is known
that caspase-1 activation by ATP is mediated throughthe P2X7 receptor and subsequent K
+ efflux (Solle
et al., 2001), further studies will be required to elucidate
the upstream events linking ATP plus TLR stimulation to
NALP3. Recent work has suggested that human NALP3
may function as an intracellular pattern recognition re-
ceptor, specifically for bacterial MDP (Martinon et al.,
2004). Our studies suggest that NALP3 plays a far
more central role in the activation of caspase-1 and is re-
quired for the ATP-driven activation of caspase-1 in re-
sponse to multiple TLR ligands. Unlike human mono-
cytes, mouse macrophages do not secrete IL-1b in
response to MDP alone (Figure 3D) and will secrete IL-
1b in response to TLR stimulation plus ATP in the ab-
sence of MDP. As the possibility of MDP contamination
of TLR agonists such as LPS and LTA could not be com-
pletely ruled out, due to the method of preparation of
these agonists from bacterial sources, we looked at
macrophage responses to synthetic lipid A. NALP32/2
macrophages were also unable to secrete IL-1b in re-
sponse to stimulation with synthetic lipid A plus ATP
(Figure 3C), confirming that the results seen with TLR
agonists are not a result of MDP contamination.
The autoinflammatory disorders MWS, FCAS, and
CINCA are characterized by bouts of fever, arthralgias,
and rash. These disorders are associated with over 20
distinct mutations in the NACHT domain of NALP3, re-
sulting in the spontaneous activation of caspase-1 and
the secretion of IL-1b (Agostini et al., 2004; Dode et al.,
2002; Feldmann et al., 2002; Hoffman et al., 2001). This
has been demonstrated with monocytes from patients
with Muckle-Wells syndrome, who spontaneously se-
crete active IL-1b (Agostini et al., 2004). This hypersecre-
tion of IL-1b has provided a rationale for therapy; nota-
bly, the administration of the IL-1b antagonist IL-1Ra
has proven to be highly successful in abrogating dis-
ease severity (Hawkins et al., 2003; Hoffman et al.,
2004). Our data help support the hypothesis that the mu-
tations within NALP3 seen in MWS, FCAS, and CINCA
result in a constitutively active form of NALP3 that leads
to the spontaneous activation of caspase-1 (Dowds
Immunity
324Figure 6. Reduced Contact Hypersensitivity Response in ASC- and
NALP3-Deficient Mice
(A and B) (A) ASC+/+ and ASC2/2mice or (B) NALP3+/+ and NALP32/2
mice were sensitized on the abdomen and chest by topical applica-
tion of 0.15 ml 5% TNP-Cl on 2 consecutive days (closed bars) or
were left unsensitized (open bars). A total of 4 days later, zero time
ear thickness was measured before challenge via topical application
to both sides of both ears of 10 ml 0.4% TNP-Cl. The subsequent in-
crease in ear thickness was measured at 24 hr. Data in (A) represent
the mean6 SD for four (nonsensitized) and five (sensitized) mice per
group. Data in (B) represent the mean6 SD for three (nonsensitized)
and four (sensitized) mice per group and are representative of three
separate experiments.
(C) C57BL/6 mice were sensitized on the abdomen and chest by top-
ical application of 0.15 ml 5% TNP-Cl on 2 consecutive days. A total
of 4 days later, spleens and axillary and inguinal lymph nodes were
isolated from sensitized mice, made into a single cell suspension,
and injected intravenously into unsensitized NALP3+/+ and
NALP32/2 mice at a 1:1 ratio. Mice were then challenged via topical
application to both sides of both ears of 10 ml 0.4% TNP-Cl. Increase
in ear thickness was measured at 24 hr. Data represent the mean 6
SD for two nonsensitized mice with no cell transfer, two sensitized
mice with no cell transfer, and five nonsensitized mice with cell
transfer per group.et al., 2004). MWS and FCAS both have significant skin
manifestations that abate after treatment with IL-1Ra
(Hawkins et al., 2003; Hoffman et al., 2004). This led us
to examine the role of ASC and NALP3 in contact hyper-
sensitivity responses. Both ASC- and NALP3-deficient
mice displayed an impaired contact hypersensitivity re-
sponse to the hapten TNP-Cl (Figures 6A and 6B). This
defect in contact hypersensitivity seen in ASC- and
NALP3-deficient mice is likely due to their impaired IL-
1b secretion, which is consistent with studies that
have shown IL-1b-deficient mice to have similar impair-
ment in their contact hypersensitivity response to TNP-
Cl (Shornick et al., 1996).
NALP3-deficient mice remained susceptible to endo-
toxic shock (Figure 4B), which is in marked contrast to
the protection from endotoxic shock-mediated mortality
seen in ASC-deficient mice challenged with the same
dose of LPS. Some degree of protection from the lethal
effects of endotoxin was observed in NALP32/2 mice
challenged with lower doses of LPS (Figure 4D). These
data demonstrate that, although NALP3 is important
for ATP-driven caspase-1 activation in response to
TLR stimulation, it is only partially responsible for the le-
thal effects of endotoxin. It remains unclear from these
studies how caspase-1 is involved in causing injury in re-
sponse to endotoxin, but it appears to be only partially
NALP3 dependent. The distinct roles of ASC and
NALP3 in caspase-1 activation could again be demon-
strated in response to S. typhimurium infection of mac-
rophages. Macrophages infected with S. typhimurium
undergo a caspase-1-dependent cell death (Hueffer
and Gala´n, 2004). We show thatS. typhimurium-induced
cell death is, however, not NALP3 dependent, and that
S. typhimurium can activate caspase-1 independently
of NALP3 (Figures 5A and 5B). It is interesting that S. ty-
phimurium activates caspase-1 via another NLR family
member, namely, IPAF. Recent studies have shown
that IPAF-deficient macrophages were resistant to S. ty-
phimurium-induced cell death (Mariathasan et al., 2004).
ASC also plays a role in this process, as caspase-1 acti-
vation is not observed in ASC-deficient macrophages
infected with S. typhimurium, and there is a delay in S.
typhimurium-induced cell death in ASC-deficient mac-
rophages (Mariathasan et al., 2004). Thus, ASC seems
to play a role as a common downstream factor for
both NALP3 and IPAF. The activation of caspase-1
within a macrophage can lead to two distinct endpoints,
i.e., the processing of the proinflammatory cytokines IL-
1b and IL-18, and caspase-1-dependent cell death in-
duced by pathogens such as Salmonella, Shigella, and
Yersinia. It remains unclear as to how caspase-1 can
be specifically activated to process IL-1b and IL-18 but
not lead to cell death. We observed that NALP3 is in-
volved specifically in the activation of caspase-1 for pro-
cessing of proinflammatory cytokines, but not Salmo-
nella-induced cell death, while IPAF is known to be
required for Salmonella-induced cell death, but not for
cytokine processing by ATP plus TLR ligands (Mariatha-
san et al., 2004). Thus, NALP3 and IPAF seem to be key
players in assigning the direction of caspase-1 activity
toward cytokine processing and/or cell death. In ad-
dition to NALP3 and IPAF, other NALP subfamily pro-
teins, which carry Pyrin and/or CARD domains, may
also be responsible for regulating caspase-1 activity
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325by converging signals from various stimuli to ASC. Anal-
ysis of mice lacking these molecules will help reveal their
roles in caspase-1 function.
Experimental Procedures
Generation of ASC- and NALP3-Deficient Mice
ASC (Figure S2A) and NALP3 (Figure S3A) targeting vectors were
electroporated into 129SvEvBrd Lex-1 embryonic stem (ES) cells.
Homologous recombinant ES cells were identified by Southern
blot analysis and were microinjected into C57BL/6 blastocysts. Chi-
meric offspring were backcrossed to C57BL/6 mice, and germline
transmission was confirmed by PCR of tail genomic DNA (Figures
S2B and S3B). Screening of ASC mice with the primers 50-
GTGGACGGAGTGCTGGATG-30 and 50-GTCCATCACCAAGTAGG
GATG-30 amplifies a 185 bp product from the wild-type allele;
primers 50-GTCCATCACCAAGTAGGGATG-30 and 50-GCTGACCGC
TTCCTCGTGCTTTAC-30 amplify a 275 bp product from the targeted
allele. PCR genotyping from NALP3 tail genomic DNA with primers
50-GCTGTGCCCAGGTCCTAGC-30 and 50-CAGCAGCAGCCCTTTC
GAG-30 amplify a 431 bp wild-type band; primers 50-CGGTGGTTGC
TAGGAGATGG-30 and 50-ATCGCCTTCTTGACGAGTTC-30 amplify
a 317 bp targeted band. RT-PCR analysis of cDNA isolated from
ASC+/+, ASC+/2, and ASC2/2 (Figure S2C) and NALP3+/+, NALP3+/2,
and NALP32/2 (Figure S3C) splenocytes confirmed the absence of
ASC and NALP3 mRNA in ASC2/2 and NALP32/2mice, respectively.
Primers used for RT-PCR analysis were as follows: NALP3, 50-
CTGAAGATGACGAGTGTCCGTT-30, 50-CTCGGGCTCAAACAGCAG
CTCCAGCTTAA-30; ASC, 50-GCGAGCAGCAGCAAGAGTAAAA-30,
50-TACTTCAGCTCTGCTCCAGGT-30.
ASC- and NALP3-deficient mice were backcrossed onto the
C57BL/6 genetic background for at least four generations. ASC+/2
and NALP3+/2 mice were each intercrossed to generate mutant
and control mice. All procedures used in this study complied with
federal guidelines and institutional policies by the Yale animal care
and use committee.
Macrophages and CD4+ T Cells
Bone marrow-derived macrophages were generated as previously
described (Sutterwala et al., 1997). Thioglycollate-elicited peritoneal
macrophages were generated by injecting 1 ml 3% thioglycollate so-
lution into the peritoneal cavity of mice. A total of 4–5 days later,
macrophages were collected by peritoneal lavage and plated in
DMEM supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml
penicillin G, and 100 mg/ml streptomycin. CD4+ T cells were pre-
pared from lymph node and spleen cells by immunomagnetic nega-
tive selection as described previously (Kamogawa et al., 1993). Cells
were cultured in Bruff’s medium supplemented with 10% FCS, L-
glutamine, penicillin, and streptomycin. CD4+ T cells were stimu-
lated with plate bound antibodies to CD3 and CD28 and 20 U/ml re-
combinant mouse IL-2 and (Th0) anti-IFNg and anti-IL-4 or (Th1) 3.5
ng/ml rIL-12 and anti-IL-4 or (Th2) 500 U/ml rIL-4 and anti-IFNg. Ef-
fectors were collected after 4 days of culture and were used to gen-
erate cDNA.
RT-PCR and SYBR Green Quantitative RT-PCR Analysis
RNA was isolated from various C57BL/6 mouse tissues by using Tri-
zol (Invitrogen, Carlsbad, CA). cDNA was synthesized by using Su-
perScript II reverse transcriptase (Invitrogen). The primers used for
RT-PCR amplification were as follows: HPRT, 50-GTTGGATACA
GGCCAGACTTTGTTG-30, 50-GAGGGTAGGCTGGCCTATAGGCT-30;
NALP3, 50-CTGAAGATGACGAGTGTCCGTT-30, 50-ATGCTGCAGTT
TCTCCAAGGCT-30. Quantitative RT-PCR analysis was performed
by using iQ SYBR Green I Supermix in the iCycler thermal cycler
(Bio-Rad, Hercules, CA) with the following primers: NALP3, 50-CGA
GACCTCTGGGAAAAAGCT-30 and 50-GCATACCATAGAGGAATGT
GATGTACA-30.
Western Blotting
Electrophoresis of proteins was performed by using the NuPAGE
system (Invitrogen) according to the manufacturer’s protocol.
Briefly, bone marrow-derived macrophages stimulated with or with-
out LPS and/or ATP were collected and lysed in NuPAGE sampleloading buffer (Invitrogen). Proteins were separated on a NuPAGE
gel and were transferred to PVDF membrane by electroblotting. To
detect caspase-1 and IL-1b, rabbit polyclonal anti-mouse ca-
sapse-1 p10 antibody (Santa Cruz Biotechnology, Santa Cruz, CA)
and goat polyclonal anti-mouse IL-1b antibody (R&D Systems, Min-
neapolis, MN) were used, respectively.
Cytokine ELISA Measurements and TLR Agonists
Lipoteichoic acid from Staphylococcus aureus, peptidoglycan from
Escherichia coli serotype 0111:B4, and LPS from E. coli serotype
0111:B4 were purchased from Invivogen (San Diego, CA). Synthetic
lipid A, LA-15-PP, was purchased from Peptide International (Louis-
ville, KY). MDP was purchased from Sigma (St. Louis, MO). Thiogly-
collate-elicited peritoneal macrophages were stimulated with the in-
dicated TLR agonist for 16 hr, and culture supernatants were
assayed for TNFa, IL-6, and IL-12 p40. The TLR-stimulated macro-
phages were cultured for an additional 20 min in the presence of
5 mM ATP (Sigma), washed, and then incubated for an additional
3 hr in fresh culture medium. Culture supernatants were then as-
sayed for IL-1a, IL-1b, and IL-18. Antibody pairs for TNFa and IL-
1a ELISAs were from eBiosciences (San Diego, CA). Antibody pairs
for IL-6 and IL-12 p40 ELISAs were from BD Pharmingen (San Diego,
CA). The IL-1b ELISA kit was from R&D Systems. Antibody pairs for
the IL-18 ELISA were from MBL (Woburn, MA).
Endotoxic Shock
Mice (8–12 weeks old) were injected intraperitoneally with 37.5,
18.75, or 9.38 mg/kg E. coli LPS (serotype 0111:B4; Sigma). Mice
were monitored for lethality twice daily for a total of 7 days. For se-
rum cytokine measurements, a separate cohort of mice received
37.5 mg/kg LPS; 5 hr later, mice were euthanized and blood was col-
lected by cardiac puncture.
S. typhimurium Infection of Macrophages
The S. typhimurium strain SB161, which carries a nonpolar mutation
in the invG gene, has been previously described (Kaniga et al., 1994).
In vitro infection of macrophages with S. typhimurium was per-
formed as described (Chen et al., 1996). Briefly, bone marrow-de-
rived macrophages were seeded in 24-well dishes at 2 3 105 cells/
well. A total of 18 hr later, nonadherent cells were removed, and
macrophages were further incubated for 4 hr in DMEM supple-
mented with 10 % FCS, 2 mM L-glutamine, and 50 ng/ml LPS. Before
infection, the medium was replaced with serum-free HBSS. Macro-
phages were then infected with wild-type S. typhimurium or the invG
mutant S. typhimurium strain SB161 at an MOI of 10 or 20 bacteria
per macrophage as indicated. After 25 min, culture supernatants
were supplemented with 100 mg/ml gentamicin, added to kill any ex-
tracellular bacteria. Macrophage cell death was determined at the
indicated time points by LDH release by using a cytotoxicity (LDH)
detection kit (Roche, Indianapolis, IN).
Contact Hypersensitivity
Mice (8–12 weeks old) were sensitized by topical application of
0.15 ml 5% TNP-Cl (Chemica Alta, Edmonton, Canada) in a 1:3 ace-
tone-ethanol mixture to the shaved abdomen and chest on 2 con-
secutive days. A total of 4 days later, ear thickness was measured
with an engineer’s micrometer (Mitutoyo Mfg. Co., Aurora, IL) before
local ear skin challenge via topical application to both sides of both
ears of 10 ml 0.4% TNP-Cl in a 1:1 olive oil-acetone mixture. The sub-
sequent increase in ear thickness was measured at 24 hr. In all ex-
periments, a group of nonsensitized control animals was also chal-
lenged on the ears with 0.4% TNP-Cl, and the resulting background
increase in ear thickness was measured. For adoptive transfer ex-
periments, C57BL/6 mice were sensitized with 5% TNP-Cl as de-
scribed above. A total of 4 days later, spleens and axillary and ingui-
nal lymph nodes were isolated from sensitized mice, made into
a single cell suspension, and injected intravenously into unsensi-
tized NALP3+/+ and NALP32/2mice at a 1:1 ratio. Mice that received
transferred cells were challenged with 0.4% TNP-Cl, and changes in
ear thickness were measured at 24 hr.
Statistical Analysis
We performed statistical analysis by using an unpaired Student’s t
test. We considered values of p < 0.05 to be statistically significant.
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Supplemental Data including three figures are available at http://
www.immunity.com/cgi/content/full/24/3/317/DC1/.
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